HWKN

Hawkins, Inc. (HWKN) 10-K Summary

Business Context and Reporting Period

Company: Hawkins, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: March 30, 2008
Business Overview: Hawkins, Inc. is a distributor, blender, and formulator of bulk and specialty chemicals operating in three segments: Water Treatment, Industrial, and Pharmaceutical. The company operates primarily in the Upper Midwest United States, with facilities in Minnesota, Wisconsin, Iowa, North Dakota, South Dakota, Nebraska, Illinois, Michigan, Montana, Missouri, Kansas, and Wyoming.

Key Financial Metrics

Material Changes vs. Prior Period

• Sales Growth: Sales increased 22.5% to $196.4 million, driven primarily by a 30.6% increase in the Industrial segment and a 10.1% increase in the Water Treatment segment.
• Acquisition Impact: The acquisition of Trumark, Inc. (completed May 31, 2007) contributed approximately 8.0% to the sales increase in the Industrial segment. The total purchase price was approximately $6.55 million ($5.96 million cash and $588,000 stock).
• Margin Compression: Gross margin percentage decreased from 23.2% to 21.2%. This was primarily due to a shift in product mix toward higher-volume, lower-margin products and a LIFO (Last-In, First-Out) inventory charge that negatively impacted margins by 1.1%.
• Pharmaceutical Segment Recovery: Pharmaceutical sales increased 13.2% following the resolution of FDA restrictions that had limited the sale of certain products in the prior year.
• Operating Expenses: Selling, general, and administrative (SG&A) expenses increased to $28.6 million (14.6% of sales) from $26.0 million (16.2% of sales). The increase was driven by the Trumark acquisition, higher employee compensation, and ERP system depreciation, though the expense ratio improved due to sales volume growth.

Guidance, Outlook, and Risks

• Capital Expenditures: The company plans to spend approximately $8.0 million on capacity expansion, with the bulk of spending expected in fiscal 2009. Recurring capital expenditures for facilities and trucks are expected to remain comparable to the three-year average.
• Liquidity: Management anticipates funding short and long-term needs with internally generated funds. The company maintains a strong financial position with no significant debt financing anticipated.
• Key Risks:
  • Commodity Prices: Fluctuations in raw material costs (e.g., caustic soda) and the ability to pass these costs to customers impact margins.
  • Seasonality: The Water Treatment segment is seasonal, with higher sales from April to September.
  • Regulatory/Environmental: Compliance with environmental laws and potential liabilities from hazardous substance handling.
  • Customer Concentration: No single customer represents more than 10% of sales, but the loss of the five largest customers could have a material adverse effect.

Investor Verification Checklist

• Trumark Integration: Verify the realization of synergies and the full-year financial contribution of the Trumark acquisition in subsequent filings.
• LIFO Reserve Impact: Monitor the LIFO reserve balance and its sensitivity to rising raw material costs, as this directly impacts reported gross margins.
• Capital Expenditure Execution: Track the $8.0 million planned capacity expansion spending in fiscal 2009 and its impact on cash flow.
• Pharmaceutical Segment Stability: Confirm that FDA restrictions remain resolved and that the segment maintains its recovered sales trajectory.
• Lease Renewals: Review the status of land leases for the three main terminals (St. Paul, MN), which are critical for bulk chemical storage and have renewal dates extending to 2018 and 2029.